文献速递类风湿关节炎

类风湿关节炎与肠道通透性增加及细菌易位相关,且控制炎症后可逆转

Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control.
PubMed 文献 · Rheumatology (Oxford) · 2022-08-10

在20例类风湿关节炎(RA)患者和20例年龄性别匹配对照的结肠活检中,RA患者紧密连接蛋白ZO-1表达低于对照;另一队列59例RA(21例未用DMARDs,其中17例在csDMARDs治疗前后;38例重症RA在bDMARDs治疗前后)和33例健康对照中,RA患者血清LBP和sCD14升高,且与DAS28相关;bDMARD应答者LBP和sCD14显著降低。

要点

  • RA患者结肠ZO-1蛋白表达低于对照(平均评分1.6±0.56 vs 2.0±0.43,p=0.01)。
  • RA患者血清LBP和sCD14高于对照,且与DAS28相关(r=0.61,p=0.005;r=0.57,p=0.01)。
  • bDMARD应答者LBP和sCD14显著降低,非应答者和csDMARDs治疗者未降低。

核心结论

  • RA患者结肠紧密连接蛋白改变,血清肠道通透性生物标志物升高。
  • 肠道通透性血清标志物与疾病活动度及bDMARD应答相关。
  • 这些结果提示RA中肠道完整性受损与全身炎症之间存在关联。

研究设计与样本

  • 研究纳入20例RA患者和20例年龄性别匹配对照,用免疫组化定量结肠活检中ZO-1、occludin和claudin 2,由两名盲法独立阅片者评估染色强度。
  • 另一队列纳入59例RA(21例未用DMARDs,其中17例在csDMARDs引入前后;38例重症RA在bDMARDs引入前后)和33例健康对照,用ELISA检测血清LBP、sCD14和zonulin相关蛋白(ZRP)。

主要发现

  • RA患者结肠ZO-1蛋白表达低于对照(平均评分±SEM为1.6±0.56 vs 2.0±0.43;p=0.01),occludin和claudin-2无显著差异。
  • RA患者血清LBP和sCD14浓度高于对照。
  • LBP与DAS28相关(r=0.61,p=0.005),sCD14与DAS28相关(r=0.57,p=0.01),ZRP与DAS28不相关。
  • bDMARD应答者LBP和sCD14浓度显著降低,bDMARD非应答者和csDMARDs治疗患者未降低。

关键数值与推荐

  • RA患者vs对照:结肠ZO-1平均评分1.6±0.56 vs 2.0±0.43(p=0.01)。
  • LBP与DAS28:r=0.61,p=0.005;sCD14与DAS28:r=0.57,p=0.01。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: to assess how rheumatoid arthritis (RA) and Disease Modifying Anti Rheumatic Drugs (DMARDs) affect gut permeability. METHODS: to explore colonic mucosa integrity, tight junction proteins ZO-1, occludin and claudin 2 were quantified by immunohistochemistry on colonic biopsies in 20 RA patients and 20 age- and sex-matched controls. Staining intensity was assessed by two blinded independent readers. To explore intestinal permeability, serum concentrations of LPS-binding protein (LBP), sCD14 and zonulin-related proteins (ZRP) were evaluated by ELISA in another cohort of 59 RA: 21 patients naive of DMARDs (17 before and after introduction of a conventional synthetic (cs) DMARDs), 38 patients with severe RA (before and after introduction of a biological (b) DMARDs), and 33 healthy controls. RESULTS: Z0-1 protein was less expressed in colon of RA patients than controls (mean score ± SEM of 1.6 ± 0.56 vs 2.0 ± 0.43; p= 0.01), while no significant difference was detected for occludin and claudin-2. RA patients had higher serum LBP and sCD14 concentrations than controls. LBP and sCD14 levels were significantly correlated with DAS28 (r = 0.61, p= 0.005 and r = 0.57, p= 0.01, respectively) while ZRP did not. bDMARD responders had significantly reduced LBP and sCD14 concentrations unlike bDMARDs non-responders and patients treated with csDMARDs. CONCLUSION: RA patients have altered colonic tight junction proteins and increased serum biomarkers of intestinal permeability. There was a correlation between serological markers of intestinal permeability and disease activity as well as bDMARD response. These results suggest a link between impaired gut integrity and systemic inflammation in RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Audo R, Sanchez P, Rivière B, et al. Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control. Rheumatology (Oxford). 2022. PMID: 35947472. doi:10.1093/rheumatology/keac454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。